Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Almonertinib hydrochloride (HS-10296 hydrochloride) is a small molecule inhibitor of EGFR-activating mutations and T790M-resistant mutation with limited activity against wild-type EGFR.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 93.00 | |
5 mg | In stock | $ 195.00 | |
10 mg | In stock | $ 328.00 | |
25 mg | In stock | $ 565.00 | |
50 mg | In stock | $ 793.00 |
Description | Almonertinib hydrochloride (HS-10296 hydrochloride) is a small molecule inhibitor of EGFR-activating mutations and T790M-resistant mutation with limited activity against wild-type EGFR. |
Targets&IC50 | EGFR (T790M):0.37 nM (IC50), EGFR (del19/T790M):0.214 nM (IC50), EGFR (L858R/T790M):0.29 mM (IC50) |
In vitro | HS-10296 hydrochloride is an orally available inhibitor of the epidermal growth factor receptor (EGFR) mutant form T790M, with potential antineoplastic activity, which canbe used to treat NSCLC[1]. |
Synonyms | HS-10296 hydrochloride |
Molecular Weight | 562.1 |
Formula | C30H36ClN7O2 |
CAS No. | 2134096-03-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 83.33 mg/mL (148.25 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Almonertinib hydrochloride 2134096-03-8 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR HS10296 non-small inhibit oral cancer lung HS-10296 hydrochloride del19 antineoplastic HS-10296 mutations Epidermal growth factor receptor L861Q HS 10296 Hydrochloride G719X Inhibitor NSCLC HS-10296 Hydrochloride Almonertinib Hydrochloride ErbB-1 HS10296 Hydrochloride L858R cell Almonertinib HS 10296 HER1 inhibitor